Pliant Therapeutics, Inc.
NASDAQ:PLRX
1.54 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -210.304 | -161.336 | -123.321 | -97.263 | -41.533 | -0.631 | -30.276 | -18.333 |
| Depreciation & Amortization
| 2.125 | 1.841 | 1.823 | 1.535 | 1.31 | 1.113 | 0.666 | 0.292 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | -12.195 | 0 | 0 |
| Stock Based Compensation
| 37.626 | 44.483 | 22.598 | 10.437 | 3.895 | 1.829 | 0.228 | 0.033 |
| Change In Working Capital
| 9.089 | 1.251 | 4.217 | 6.917 | -1.209 | -5.061 | 1.054 | 0.893 |
| Accounts Receivables
| 0 | 1.983 | 0.015 | 7.281 | -2.227 | -7.052 | -0.25 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0.113 | 3.196 | 0 | 0 |
| Accounts Payables
| 1.428 | 2.969 | -1.351 | 0.891 | 0.922 | -1.255 | 0.76 | 0 |
| Other Working Capital
| 7.661 | -3.701 | 5.553 | -1.255 | -0.017 | 0.05 | 0.294 | 0.893 |
| Other Non Cash Items
| 5.961 | -2.6 | 0.052 | 2.931 | 0.266 | 12.195 | 1.05 | 0.191 |
| Operating Cash Flow
| -155.503 | -116.361 | -94.631 | -75.443 | -37.271 | -2.75 | -28.328 | -16.924 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -3.848 | -0.921 | -1.76 | -1.953 | -1.532 | -0.964 | -2.323 | -1.405 |
| Acquisitions Net
| 0 | 0 | 148.444 | -75.652 | 209.334 | 0.254 | 0 | 0 |
| Purchases Of Investments
| -211.285 | -583.069 | -325.716 | -219.887 | -322.605 | -51.967 | 0 | 0 |
| Sales Maturities Of Investments
| 355.473 | 456.978 | 177.272 | 295.539 | 113.271 | 35 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -148.444 | 75.652 | -209.334 | -0.254 | 0 | 0 |
| Investing Cash Flow
| 140.34 | -127.012 | -150.204 | 73.699 | -210.866 | -17.931 | -2.323 | -1.405 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 3.207 | 275.252 | 217.561 | 2.984 | 161.193 | 0.174 | 0.032 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.012 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 19.91 | -0.847 | 216.854 | -0.457 | 52.019 | 45.365 | 174.666 | 20.018 |
| Financing Cash Flow
| 23.117 | 274.405 | 226.854 | 2.527 | 213.212 | 45.539 | 87.349 | 20.006 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 7.954 | 31.032 | -17.981 | 0.783 | -34.925 | 24.858 | 56.698 | 1.677 |
| Cash At End Of Period
| 72.67 | 64.716 | 33.684 | 51.665 | 50.882 | 85.807 | 60.949 | 4.251 |